Eight patients showed an increasing trend over time, particularly at 12 months or more following diagnosis, while three other patients exhibited a slight decrease or stable course of Spp1 levels.
← all excerpts
Association of serum Spp1 levels with disease progression in ALS and SBMA.
1
—
—